Navigation Links
Varian Medical Systems Management to Present at Jefferies 2012 Global Healthcare Conference
Date:11/5/2012

PALO ALTO, Calif., Nov. 5, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) is scheduled to present at Jefferies 2012 Global Healthcare Conference at 10:40 a.m. GMT on Thursday, November 15, at the Waldorf Hilton in London.

Participating executives will be Spencer Sias, vice president of investor relations and corporate communications, and Neil Madle, director of investor relations Europe.  The presentation will focus on the company's growth opportunities in radiation oncology, X-ray imaging, proton therapy and security and inspection.

For automatic "e-mail alerts" regarding Varian news, events, and new investor materials on the website, investors can subscribe on the company website:
http://varian.investorroom.com/index.php?s=58. For additional information, contact investor relations at 1 650 424-5834.

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 6,100 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com.


'/>"/>
SOURCE Varian Medical Systems
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Varian Medical Systems Management to Present at Lazard Capital Markets 9th Annual Healthcare Conference
2. Varian Medical Systems Selected by Leading Russian Development Foundations to Take Part in High-Profile Supplier Event
3. RayBiotech, Inc. and Abeome Corporation Announce an Agreement Related to Novel Research Products for Ovarian Cancer
4. American Board of Radiology Foundation receives grant from Varian Medical Systems for national brachytherapy registry
5. Varian Medical Systems to Proceed with Year End Review and Webcast for Investors at ASTRO Meeting in Boston
6. Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2012
7. Varian Medical Systems Signs Purchase Agreement with Advanced Particle Therapy LLC to Supply Technology for the Georgia Proton Treatment Center to be operated by Emory Healthcare
8. Varian Medical Systems Publishes 2012 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
9. Institut Curie Acquires Four Advanced Radiotherapy Treatment Systems Including Three Varian TrueBeam Devices
10. Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer
11. Varian Medical Systems Establishes Subsidiary in South Korea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... YORK , Feb. 23, 2017  This report ... Thousand by the following Products: Intermediates, ... in the report include Pharmaceuticals, and Agrochemicals. The report ... Japan , Europe , and ... for the period 2015 through 2022. Also, a six-year ...
(Date:2/24/2017)... YORK , Feb. 23, 2017  The ... 330.6 million by 2021 from USD 275.9 million ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... increasing spending on pharmaceutical R&D, and growth in ... driving the market growth for particle counters. On ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an ... that it has acquired exclusive worldwide rights to ... innovative HDAC inhibitor targeting hematological and solid tumors. ... Phase 1 and 2 clinical trials of Abexinostat ... have already been completed, demonstrating that Abexinostat ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, ... with The Jensie Gran Fondo of Marin. For the second year in a ... broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide our safe, non-toxic sunscreen ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Club in Miami Beach to host its Swirl: Miami Wine Tasting Event on ...
(Date:2/23/2017)... ... ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., F.AC.S. will be appearing ... which will begin airing on February 24, 2017. The show chronicles the weight loss ... television series, “Here Comes Honey Boo Boo.” The earlier series from TLC lasted for ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... approved content provider for the National Institute for Health and Care Excellence ... care-related organizations in the National Health Service (NHS) to search, order and purchase ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig ... where generations converge and explore the world from different perspectives. By providing a ... readers to gain understanding, increase empathy, and find greater happiness. , "Our ...
Breaking Medicine News(10 mins):